Related Experiment Video
Updated: Jun 25, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
Discovery of anti-varicella zoster virus activity of polyether antibiotic CP-44161
Yukiko Yamagishi1, Chihoko Ueno, Akemi Kato
1Fermentation Research Labs, Astellas Pharma Inc., Tsukuba-shi, Ibaraki, Japan. yukiko.yamagishi@jp.astellas.com
Abstract:
In search for new anti-varicella zoster virus (VZV) compounds with new mechanism of action, we applied a DNA hybridization assay (dot blot method) for screening. Using this method, we screened microbial products and found the polyether compound CP-44161 from the culture broth of an actinomycete strain. CP-44161 was previously reported as an anticoccidal agent, but there has been no claim of its antiviral activities. CP-44161 showed strong anti-VZV activity against pOka strain by plaque reduction assay. Moreover, CP-44161 showed lower cytotoxicity than other antiviral polyethers, such as monensin and nigericin. Its better safety margin and strong anti-VZV properties make it a good candidate for a new anti-VZV agent.
More Related Videos
Related Concept Videos
Chickenpox
Antiviral Nucleoside Inhibitors
Smallpox
Respiratory Syncytial Virus Disease
Poliomyelitis
Cross-reactivity

